Feedback / Questions
Stalaris (efzofitimod) - aTyr Pharma, Kyorin
https://www.globenewswire.com/news-release/2025/06/04/3093518/0/en/aTyr-Pharma-Announces-Findings-from-Interim-Analysis-of-Ongoing-Phase-2-EFZO-CONNECT-Study-of-Efzofitimod-in-Systemic-Sclerosis-Related-Interstitial-Lung-Disease-SSc-ILD.html
Jun 4, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next